{"id":5339,"date":"2019-06-15T15:39:17","date_gmt":"2019-06-15T13:39:17","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/preomics-erhaelt-33-millionen-fuer-eine-serie-a-finanzierung\/"},"modified":"2020-07-03T09:34:50","modified_gmt":"2020-07-03T07:34:50","slug":"preomics-receives-3-3-million-euro-for-a-series-a-financing","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/preomics-receives-3-3-million-euro-for-a-series-a-financing\/","title":{"rendered":"PreOmics receives 3.3 million euro for a Series A financing"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

PreOmics receives 3.3 million euro for a Series A financing
\n<\/span><\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]June 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]The start-up based at the IZB that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry raised 3.3 million euro in series A funding. The round was led by Think. Health Ventures with participation from High-Tech Gr\u00fcnderfonds and business angels. The company intends to use the funds for the continued internationalization of the business and the development of further products. With its technology, the company offers a solution for processing samples for mass spectrometry, which is currently performed using homemade protocols. These processes are often slow, not reproducible, not robust and cannot be automated. PreOmics technology manages to reduce the protocols\u2019 amount of work significantly. PreOmics was founded in August 2016 by Dr. Garwin Pichler and Dr. Nils Kulak. The two scientists worked in the proteomics research group of Prof. Matthias Mann at the Max Planck Institute of Biochemistry.[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote”][vc_column_inner][vc_single_image image=”5337″ img_size=”155×155″ alignment=”center” style=”vc_box_circle_2″][vc_column_text el_class=”gco-magazine–picture-discription-blank”]<\/p>\n

\u00a9 PreOmics GmbH<\/p>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-copyright-blank”]<\/p>\n

\u00a9 PreOmics GmbH<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n